𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The clinical implications of antitumor immunity in head and neck cancer

✍ Scribed by Clint T. Allen; Nancy P. Judd; Jack D. Bui; Ravindra Uppaluri

Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
319 KB
Volume
122
Category
Article
ISSN
0023-852X

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Recent developments have renewed interest in understanding the interaction between transformed cells and the immune system in the tumor microenvironment. Here, we provide a comprehensive review addressing the basics of tumor immunology in relation to head and neck cancer and the cellular components potentially involved in antitumor immune responses. In addition, we describe the mechanisms by which head and neck cancer cells escape immune‐mediated killing and progress to form clinically significant disease. Further, we detail what effects standard anticancer therapies may have on antitumor immune responses and how these responses may be altered by current and investigational immunotherapies. Finally, we discuss future directions that need to be considered in the development of new immunotherapeutics designed to durably alter the immune response in favor of the host.Laryngoscope, 122:144–157, 2012

πŸ“œ SIMILAR VOLUMES

Cell-mediated immune response in head an
Cell-mediated immune response in head and neck cancer patients
✍ Dr. A. Olivari; R. Pradier; J. Feierstein; A. Guardo; H. Glait; A. Rojas πŸ“‚ Article πŸ“… 1976 πŸ› John Wiley and Sons 🌐 English βš– 381 KB

## Abstract The immune reactivity of 100 head and neck cancer patients was studied by means of DNCB, candidine, blastic transformation with PHA, and lymphocyte counts. DNCB reactivity was strong in only 21% of the population and was found impaired in patients with advanced primitive tumors, with m

Regulatory T cells: What role do they pl
Regulatory T cells: What role do they play in antitumor immunity in patients with head and neck cancer?
✍ Osama Alhamarneh; Shoba M. P. Amarnath; Nicholas D. Stafford; John Greenman πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 175 KB πŸ‘ 1 views

## Abstract Advances in the treatment modalities for head and neck squamous cell carcinoma (HNSCC) over the last 20 years involving surgery, radiotherapy, chemotherapy, and immunotherapy are not fully reflected in increases in the 5‐year survival rates, mainly due to locoregional recurrences and to

Mechanisms of immune suppression in pati
Mechanisms of immune suppression in patients with head and neck cancer: Influence on the immune infiltrate of the cancer
✍ M. Rita I. Young; Mark A. Wright; Yvonne Lozano; John P. Matthews; Janet Benefie πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 French βš– 789 KB

Freshly excised human head and neck cancers (2 I9 primary cancers; 64 metastatic lymph node cancers) were analyzed for the immune inhibitory mediators released from the cancer tissues and the immune infiltrate within the tumor. Significant levels of the immune inhibitory mediators transforming growt

Management of the clinically negative ne
Management of the clinically negative neck in early-stage head and neck cancers after transoral resection
✍ Juan P. Rodrigo; Jatin P. Shah; Carl E. Silver; Jesus E. Medina; Robert P. Takes πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 126 KB πŸ‘ 2 views

## Abstract The decision regarding treatment of the clinically negative neck has been debated extensively. This is particularly true with early‐stage tumors for which surgery is the treatment of choice, and the tumor has been resected transorally without a cervical incision. Elective neck dissectio